The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid

Ophthalmology

Volumn 109, Issue 1, 2002, Pages 111-118

  Miserocchi, Elisabetta ^a   Baltatzis, Stefanos ^a   Roque, Manolette R ^a   Ahmed, A Razzaque ^b   Foster, C Stephen ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; TACROLIMUS;

ADULT; AGED; ANEMIA; ARTICLE; BLINDNESS; BLOOD DISEASE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORNEA DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRY EYE; ENDOCRINE DISEASE; EYE DISEASE; EYE INFLAMMATION; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLAUCOMA; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY TRACT DISEASE; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; AZATHIOPRINE; CONJUNCTIVITIS; CYCLOPHOSPHAMIDE; DAPSONE; DISEASE PROGRESSION; DRUG HYPERSENSITIVITY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PREDNISONE; VISUAL ACUITY;

EID: 0036135717     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00863-6     Document Type: Article

References (36)

1. Cicatricial pemphigoid
2. Ocular cicatricial pemphigoid
3. Progression of disease in ocular cicatricial pemphigoid
4. Immunologic aspects of cicatricial pemphigoid
5. Antibodies against conjunctival basement membrane zone: Occurrence in cicatricial pemphigoid
6. The acute manifestations of ocular cicatricial pemphigoid: Diagnosis and treatment
7. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines
8. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity
9. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid
10. Ocular cicatricial pemphigoid antigen: Partial sequence and biochemical characterization
11. The role of antibody to human β4 integrin in conjunctival basement membrane separation: Possible in vitro model for ocular cicatricial pemphigoid
12. Long term results of systemic chemotherapy for ocular cicatricial pemphigoid
13. Systemic chemotherapy for ocular cicatricial pemphigoid
14. Benign mucous membrane pemphigoid
15. Immunosuppressive therapy in ocular cicatricial pemphigoid
16. Immunosuppressive and cytotoxic drugs in dermatology
17. Azathioprine in the treatment of muco-cutaneous pemphigoid
18. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid
19. Systemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular disease
20. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. A preliminary study
21. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone
22. Remission and recurrences after withdrawal of therapy for ocular cicatricial pemphigoid
23. Bullous pemphigoid responding to sulfapyridine and the sulfones
24. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid
25. Sulfones and sulfonamides in dermatology today
26. Immunosuppressive drugs in immune and inflammatory ocular disease
27. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: Effects of systemic immunosuppression
28. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus
29. Destructive corneal and scleral disease associated with rheumatoid arthritis: Medical and surgical management
30. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy
31. Ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature
32. Immunosuppressive therapy for severe chronic uveitis
33. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant uveitis associated with juvenile rheumatoid arthritis
34. Immunosuppressants and prednisone in pemphigus vulgaris. Therapeutic results obtained in 63 patients between 1961 and 1975
35. The complications of systemic corticosteroid therapy in the elderly. A retrospective study
36. Immunosuppressive therapy for external ocular inflammatory disease